• Twitter
  • Facebook
  • Linkedin
  • Mail
GVN
COVID-19 Variants and Vaccines
  • Home
  • About
    • About
    • Mission
    • Letter from the President
    • Board of Directors
    • Senior Advisors
    • Scientific Leadership Board
    • Media Inquiries
    • GVN Team
    • Partners
    • Careers at GVN
  • GVN Members
    • GVN Academic Centers of Excellence & Affiliates
    • GVN Healthcare & Pharma Centers of Excellence Coalition
    • GVN Regional Headquarters
  • Activities
    • Research
      • GVN SARS-CoV-2 Response Effort Highlights
      • SARS-CoV-2 Task Force
      • Emerging Pathogens Discovery Network Working Group
      • Zika Virus Task Force
      • HTLV-1 Task Force
      • Chikungunya Task Force
      • Translational Medicine and Clinical Research
    • Training
      • The GVN – Abbott Pandemic Defense Postdoctoral Fellowship Program
      • GVN Drs. Yang Liu & Pan Zheng Academy Program
      • 7th Annual Short Course in Basic and Translational Virology
      • Online Course on Microbiomes and their Impact on Viral Infections
      • Short Course Alumni Database
      • Hepatitis In India
    • Advocacy
      • Initiatives
      • HTLV-1 Letter
  • Publications
    • 2021 Annual Report
    • GVN COVID-19 Perspectives
    • The Other Side of Virology: Beyond the COVID-19 Pandemic
    • GVN Weekly Brief
    • GVN Webinars
    • GVN Center/Member Publications
    • GVN Center and Member Spotlights
    • GVN Previous Publications
  • Events
    • GVN Science of Long COVID Conference
    • GVN-Monaco COVID-19 Diagnostic Conference
    • GVN Annual Meetings
    • Robert C. Gallo Award
    • Zika Virus Meeting
  • News
    • Press Releases
    • GVN in the News
    • Media Inquiries
    • GVN Weekly Brief
    • Join the GVN Mailing List
  • SARS-CoV-2
    • GVN Variants and Vaccine Resource Portal
    • Dr. Christian Brechot Blog
    • GVN Center & Member Spotlight
    • GVN COVID-19 Webinar Series
    • GVN SARS-CoV-2 Perspectives
    • GVN in the News
    • Saliva Testing for COVID-19
  • Monkeypox
  • Members Login
  • Search
  • Menu
Archived Essays Archived Videos

Publications

2020

GVN 2020 End of Year Report

2019

Meeting Report: The 10th International Global Virus Network Meeting

Meeting Report: The 11th International Global Virus Network Meeting

2018

Time to eradicate HTLV-1: an open letter to WHO

Meeting Report: The 9th International Global Virus Network Meeting.

2017

Time to go back to the original name (of HTLV).

Zika in the Americas, year 2: What have we learned? What gaps remain?

A pilot study to expand treatment of chronic hepatitis C in resource-limited settings.

Reducing the global burden of HTLV-1 infection: An agenda for research and action

The Exceptional Oncogenicity of HTLV-1.

2016

Meeting Report: The 8th International meeting of the Global Virus Network.

Screening transplant donors for HTLV-1 and -2.

2015

Chikungunya virus pathogenesis: From bedside to bench.

The Global Virus Network: Challenging chikungunya.

Chikungunya: Evolutionary history and recent epidemic spread.

A historical personal perspective on human retroviruses and their infection of T cells.

2014

The Global Virus Network’s testimony on Ebola to the U.S. Senate.

Abstracts of the 15th Annual International Meeting of the Institute of Human Virology.

Contact GVN

725 West Lombard St
Room S413
Baltimore, MD 21201
(410)-706-1966

Contact Us

Support GVN

Support

The Global Virus Network is a 501(C)3.

Join Our Mailing List

Subscribe
© Copyright - GVN - Enfold Theme by Kriesi
  • Twitter
  • Facebook
  • Linkedin
  • Mail
Scroll to top